IRVINE, Calif.--(BUSINESS WIRE)--Reverse Medical Corporation announced today that the United States Patent Office has notified the Company that a new patent (8,771,341) has issued entitled “Protuberant Aneurysm Bridging Device and Method of Use”. This new patent grants six claims surrounding the use of the Company’s BARREL Vascular Reconstruction Device (“VRD”) technology platform.
The Reverse Medical BARREL VRD represents a proprietary technology designed specifically for treating complex intracranial bifurcation artery anatomy. The BARREL design is unique, essentially reducing the neck size of wide-neck bifurcation aneurysms, enabling traditional coil embolization, a craft already mastered by the Neuro Interventionalist, while maintaining patency of all involved vasculature.
This newly issued patent builds upon Reverse’s intellectual property portfolio, which now includes seven issued patents and numerous additional pending patent applications worldwide. Commenting on this new patent, Reverse Medical Chief Technology Officer Brian Strauss said, “This patent solidifies our intellectual property foundation of unique means for treating wide-neck bifurcation aneurysms, and along with our other issued patents and pending applications, provides us with broad protection for our innovative device portfolio for treating a variety of Neuro and Peripheral vascular conditions.”
Reverse Medical Corporation is a privately held medical device company focused on expanding a technology driven pipeline of innovative, state-of-the-art endovascular treatments for a broad spectrum of peripheral and neurovascular disorders and diseases. The Company is based in Irvine, California.